These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15212308)

  • 41. Excised porcine skin experimental systems to validate quantitative microdialysis methods for determination of drugs in skin after topical application.
    Seki T; Wang A; Yuan D; Saso Y; Hosoya O; Chono S; Morimoto K
    J Control Release; 2004 Nov; 100(2):181-9. PubMed ID: 15544866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation optimization of photocrosslinked polyacrylic acid modified with 2-hydroxyethyl methacrylate hydrogel as an adhesive for a dermatological patch.
    Onuki Y; Hoshi M; Okabe H; Fujikawa M; Morishita M; Takayama K
    J Control Release; 2005 Nov; 108(2-3):331-40. PubMed ID: 16202471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel method for studying photolability of topical formulations: a case study of titanium dioxide stabilization of ketoprofen.
    Lodén M; Akerström U; Lindahl K; Berne B
    J Pharm Sci; 2005 Apr; 94(4):781-7. PubMed ID: 15729703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid UPLC-MS/MS method for the determination of ketoprofen in human dermal microdialysis samples.
    Tettey-Amlalo RN; Kanfer I
    J Pharm Biomed Anal; 2009 Nov; 50(4):580-6. PubMed ID: 19019610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
    Baboota S; Shakeel F; Kohli K
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of microemulsions in dermal and transdermal drug delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2008; 21(5):246-59. PubMed ID: 18562799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skin permeation of ketotifen applied from stick-type formulation.
    Kimura C; Nakanishi T; Tojo K
    Eur J Pharm Biopharm; 2007 Sep; 67(2):420-4. PubMed ID: 17433642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of membrane type and liquid/liquid phase boundary on in vitro release of ketoprofen from gel formulations.
    Gallagher SJ; Trottet L; Carter TP; Heard CM
    J Drug Target; 2003 Jul; 11(6):373-9. PubMed ID: 14668058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probing the skin permeation of eicosapentaenoic acid and ketoprofen 2. Comparative depth profiling and metabolism of eicosapentaenoic acid.
    Thomas CP; Heard CM
    Eur J Pharm Biopharm; 2007 Aug; 67(1):156-65. PubMed ID: 17270404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo pharmacokinetics of ketoprofen after patch application in the Mexican hairless pig.
    Horie M; Sekiya I; Nakamura T; Tanaka H; Maekawa K; Nakanishi M; Muneta T; Kobayashi E
    Biopharm Drug Dispos; 2009 May; 30(4):204-8. PubMed ID: 19434661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization.
    Alves PM; Pohlmann AR; Guterres SS
    Pharmazie; 2005 Dec; 60(12):900-4. PubMed ID: 16398265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design.
    Islam RS; Tisi D; Levy MS; Lye GJ
    Biotechnol Prog; 2007; 23(4):785-93. PubMed ID: 17592858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using cyclodextrin complexation to enhance secondary photoprotection of topically applied ibuprofen.
    Godwin DA; Wiley CJ; Felton LA
    Eur J Pharm Biopharm; 2006 Jan; 62(1):85-93. PubMed ID: 16137872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rat epidermal keratinocyte organotypic culture (ROC) compared to human cadaver skin: the effect of skin permeation enhancers.
    Pappinen S; Tikkinen S; Pasonen-Seppänen S; Murtomäki L; Suhonen M; Urtti A
    Eur J Pharm Sci; 2007 Mar; 30(3-4):240-50. PubMed ID: 17188471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Desirability-based multiobjective optimization for global QSAR studies: application to the design of novel NSAIDs with improved analgesic, antiinflammatory, and ulcerogenic profiles.
    Cruz-Monteagudo M; Borges F; Cordeiro MN
    J Comput Chem; 2008 Nov; 29(14):2445-59. PubMed ID: 18452123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
    Sintov AC; Botner S
    Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Formula optimization based on artificial neural networks in transdermal drug delivery.
    Takayama K; Takahara J; Fujikawa M; Ichikawa H; Nagai T
    J Control Release; 1999 Nov; 62(1-2):161-70. PubMed ID: 10518647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.